Pathogenic Menace of MDR Bacteria in Stool and Throat Swab Surveillance Cultures of Hematopoietic Stem Cell Recipients and Evaluation of Post-Transplant Bloodstream Infections: A Cross-Sectional Study from A Tertiary Care Teaching Hospital of Kolkata, India
DOI:
https://doi.org/10.55489/njmr.150120251035Keywords:
Bone marrow cell transplantation, Stool surveillance culture, Drug Resistance, BacteremiaAbstract
Background
Infections with multidrug-resistant organisms (MDRO) may pose a threat to hematopoietic stem cell transplant recipients. Pre-transplant surveillance culture of stool and throat swabs may guide antibiotic therapy in these groups of patients. We have conducted this study to determine the profile of organisms isolated from stool and throat swab cultures, their susceptibility pattern, and the presence of MDRO to detect post-transplant bloodstream infections in this tertiary care teaching hospital in Kolkata.
Methods
This cross-sectional study was conducted over a period of one year between 1st January to 31st December 2023. Pre-transplant surveillance culture of stool and throat swabs were performed on seventy patients from the Department of Hematology and processed in the Department of Microbiology using standard laboratory guidelines and their antibiotic susceptibility was done as per CLSI 2023 guidelines. The organisms were phenotypically screened for drug resistance and molecular confirmation was done for carbapenemases producers. Bloodstream infections in these recipients were detected by blood culture.
Results
There were 70 transplant recipients in whom stool surveillance culture yielded maximum incidence of Escherichia coli of which 32.8% were MDRO. Throat surveillance culture yielded Escherichia coli with 51.8% MDRO. blaNDM was the most common carbapenemases gene detected. Post-transplant the incidence of bloodstream infections detected by blood culture was seen in 32 recipients with Acinetobacter baumannii being the predominant Gram-negative isolate.
Conclusion
Colonization with MDRO in HSCT recipients before transplant is a potential threat. Performing stool and throat surveillance cultures before transplantation can inform empirical antibiotic strategies and tailored individualized antibiotic treatment.
References
Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 2015 Nov;21(11):1863-9. DOI: https://doi.org/10.1016/j.bbmt.2015.07.032 PMid:26256941 PMCid:PMC4830270 DOI: https://doi.org/10.1016/j.bbmt.2015.07.032
Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, et al. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. Journal of Clinical Oncology. 2017 May 20; 35(15): 1650-9. DOI: https://doi.org/10.1200/JCO.2016.70.3348 PMid:28296584 PMCid:PMC5455763 DOI: https://doi.org/10.1200/JCO.2016.70.3348
Vindigni SM, Surawicz CM. The gut microbiome: a clinically significant player in transplantation? Expert Review of Clinical Immunology. 2015 Jul 3;11(7):781-3. DOI: https://doi.org/10.1586/1744666X.2015.1043894 PMid:26065325 DOI: https://doi.org/10.1586/1744666X.2015.1043894
Satlin MJ, Walsh TJ. Multidrug‐resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin‐resistant Entero-coccus: Three major threats to hematopoietic stem cell trans-plant recipients. Transplant Infectious Disease. 2017 Dec 25;19(6):1-52. DOI: https://doi.org/10.1111/tid.12762 PMid:28815897 PMCid:PMC5745272 DOI: https://doi.org/10.1111/tid.12762
Ghosh S, Bhattacharya S, Goel G, et al. Hematopoietic stem-cell transplantation in a zoo of multidrug-resistant organisms: Data from a cancer center in eastern India. Transpl Infect Dis. 2023; e14072. DOI: https://doi.org/10.1111/tid.14072 PMid:37260056 DOI: https://doi.org/10.1111/tid.14072
CLSI. Performance Standards for antimicrobial susceptibility testing, 33rd ed M 100. Clinical and Laboratory Standards Institute; [2023].
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bac-teria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281. DOI: https://doi.org/10.1111/j.1469-0691.2011.03570.x PMid:21793988 DOI: https://doi.org/10.1111/j.1469-0691.2011.03570.x
Gill JS, Singh SP, Sharma S, Agarwal A. Gut microbiota profiling in hematopoietic stem cell transplant recipients: Towards personalized medicine. Medical Journal Armed Forces India. 2021 Jan;77(1):22-7. DOI: https://doi.org/10.1016/j.mjafi.2019.06.001 PMid:33487861 PMCid:PMC7809492 DOI: https://doi.org/10.1016/j.mjafi.2019.06.001
Korula A, Perumalla S, Devasia AJ, Abubacker FN, Lakshmi KM, Abraham A, Mathews V, Srivastava A, Anandan S, Veeraraghavan B, George B. Drug-resistant organisms are common in fecal surveillance cultures, predict bacteremia and correlate with poorer outcomes in patients undergoing allogeneic stem cell transplants. Transpl Infect Dis. 2020 Jun;22(3):e13273. DOI: https://doi.org/10.1111/tid.13273 PMid:32107829 DOI: https://doi.org/10.1111/tid.13273
Sait AS, Patole SS, Dzintars K, Cosgrove SE, Steinke SM. Rectal stool surveillance cultures to guide empiric antibiotic therapy in patients with hematologic malignancies with or without hematopoietic stem cell transplantation. Open Forum Infect Dis. 2020;7(suppl 1):S106. DOI: https://doi.org/10.1093/ofid/ofaa439.249 PMCid:PMC7777835 DOI: https://doi.org/10.1093/ofid/ofaa439.249
Shekar K, Chichra A, Garg K, Lall S, Jindal N, Mantri N, Mirgh S, Nayak L, Gokarn A, Punatar S, Mathew LJ. Molecular Pat-terns of Resistance in Carbapenem Resistant Organisms Detected in Stool Surveillance Cultures in Patients Undergoing Hematopoietic Cell Transplant. Blood. 2023 Nov 28;142:4918. DOI: https://doi.org/10.1182/blood-2023-184659 DOI: https://doi.org/10.1182/blood-2023-184659
Van Duin D, Doi Y. The global epidemiology of carbapenemase producing Enterobacteriaceae. Virulence. 2017 May 19;8(4):460-9. DOI: https://doi.org/10.1080/21505594.2016.1222343 PMid:27593176 PMCid:PMC5477705 DOI: https://doi.org/10.1080/21505594.2016.1222343
Bhat VG, Vira HJ, Kelkar RS, Biswas SK, Chavan PD. Gram Negative Bacterial Sepsis in a Cancer Centre: Bacteriological Spectrum and Antibiotic Susceptibility Profiles. J Basic Clin Pharm 2017;8:144-148.
George BMV, Srivastava A, Chandy M. Infections among allogeneicbone marrow transplant recipients in India. Bone Mar-row Transplant.2004;33(3):311-315. DOI: https://doi.org/10.1038/sj.bmt.1704347 PMid:14647246 DOI: https://doi.org/10.1038/sj.bmt.1704347
George BMV, Viswabandya A, Srivastava A, Chandy M. Infectionsin children undergoing allogeneic bone marrow transplantation inIndia. Pediatr Transplant. 2006;10(1):48-54. DOI: https://doi.org/10.1111/j.1399-3046.2005.00397.x PMid:16499587 DOI: https://doi.org/10.1111/j.1399-3046.2005.00397.x
Wang L, Wang Y, Fan X, Tang W, Hu J. Prevalence of resistant gram-negative bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation: a single center retrospective cohort study. Medicine. 2015; 94(45): e1931. DOI: https://doi.org/10.1097/MD.0000000000001931 PMid:26559260 PMCid:PMC4912254 DOI: https://doi.org/10.1097/MD.0000000000001931
Martelius T, Jalava J, Kärki T, Möttönen T, Ollgren J, Lyytikäin-enO. Nosocomial bloodstream infections caused by Escherich-ia coliand Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality. Infect Dis (Lond). 2016;229-234. DOI: https://doi.org/10.3109/23744235.2015.1109135 PMid:26577519 DOI: https://doi.org/10.3109/23744235.2015.1109135
Van der Steen M, Leenstra T, Kluytmans JAJW, van der Bij AK.Trends in expanded-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae among Dutch clini-cal isolates, from 2008 to 2012. PLoS ONE. 2015;10(9):e0138088. DOI: https://doi.org/10.1371/journal.pone.0138088 PMid:26381746 PMCid:PMC4575062 DOI: https://doi.org/10.1371/journal.pone.0138088
Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55(7):905-914. DOI: https://doi.org/10.1093/cid/cis580 PMid:22718773 PMCid:PMC3657523 DOI: https://doi.org/10.1093/cid/cis580
Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year. BMC Infect Dis. 2015 Apr 1;15:168. DOI: https://doi.org/10.1186/s12879-015-0880-5 PMid:25887288 PMCid:PMC4399485 DOI: https://doi.org/10.1186/s12879-015-0880-5
Singh R, de Groot PF, Geerlings SE, Hodiamont CJ, Belzer C, Berge IJMT, de Vos WM, Bemelman FJ, Nieuwdorp M. Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteri-aceae: a proof of principle study. BMC Res Notes. 2018 Mar 22;11(1):190. DOI: https://doi.org/10.1186/s13104-018-3293-x PMid:29566738 PMCid:PMC5863815 DOI: https://doi.org/10.1186/s13104-018-3293-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Kabita Choudhury, Sonia Deb, Suman Kundu, Baishali Dhar, Tuphan Kanti Dolai, Jayanta Bikash Dey, Swagata Ganguly Bhattacharjee
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Author/s retain the copyright of their article, with first publication rights granted to Medsci Publications.